Molecular characterisation of host cell targets of human pathogenic viruses and evaluating their potential as novel therapeutic targets.
Molecular characterisation of host cell targets of human pathogenic viruses and evaluating their potential as novel therapeutic targets.
人类病原病毒宿主细胞靶标的分子特征并评估其作为新治疗靶点的潜力。
批准号：
nhmrc : 1037092
负责人：
Dr Mohamad Aljofan
金额：
$20.53万
依托单位：
依托单位国家：
澳大利亚
项目类别：
Early Career Fellowships
财政年份：
2012
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2012-01-01 至 2014-12-31
中文摘要
翻译
目前还没有治疗亨德拉、尼帕或狂犬病病毒感染的药物，这些病毒每年在全球造成5万人死亡。通过不完全理解的机制，这些病毒影响特定细胞蛋白质的功能，以抑制宿主免疫系统，这是其致病性所必需的过程。我们的目标是阐明病毒抑制宿主免疫的机制，并评估它们作为新靶点的潜力，以开发针对这些致命病原体的迫切需要的治疗方法。
英文摘要
There are currently no therapeutics to treat victims of Hendra, Nipah or Rabies virus infections, which account for > 50,000 deaths/yr worldwide. Through not fully understood mechanisms, these viruses affect the functions of specific cellular proteins in order to inhibit the host immune system, a process essential to their pathogenicity. We aim to characterise the mechanisms underlying viral inhibition of host immunity and evaluate their potential as novel targets to develop urgently needed therapeutics against these deadly pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
